Executive Summary
Report Entitled: "Time to Nix Management"
We are pleased to issue a report outlining our concerns why Prestige Consumer Healthcare, Inc. (PBH, "Prestige Brands", or "the Company") faces 40% - 60% downside risk to approximately US$15 - $23 per share. (The full report can be found on our website). Please read our disclaimer below.
After conducting in-depth channel checks and a rigorous forensic review, Spruce Point has significant concerns about Prestige Brands, a roll-up of orphaned brand named, over-the-counter (OTC) healthcare products. Spruce Point has a history of successfully